| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/B978-0-444-53488-0.00002-X |
| P698 | PubMed publication ID | 25015480 |
| P50 | author | Philip Pellett | Q73062065 |
| P2093 | author name string | Thomas C Holland | |
| Subhash Mitra | |||
| P2860 | cites work | Overview, prevention, and treatment of rabies | Q47268712 |
| Viruses and multiple sclerosis | Q56970393 | ||
| Cytomegalovirus infections | Q84787139 | ||
| Human immunodeficiency virus and the central nervous system | Q84787144 | ||
| Uncoating of non-enveloped viruses | Q38075203 | ||
| Vaccines for measles, mumps and rubella in children | Q24203667 | ||
| Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult | Q24276386 | ||
| Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia | Q24606799 | ||
| Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain | Q24619923 | ||
| Antiviral drugs for viruses other than human immunodeficiency virus | Q24635330 | ||
| Maternal and neonatal herpes simplex virus infections | Q24653520 | ||
| Encephalitic alphaviruses | Q24655184 | ||
| Degrees of maturity: the complex structure and biology of flaviviruses | Q26824712 | ||
| Neurologic complications of HIV infection | Q26825407 | ||
| Flavivirus cell entry and membrane fusion | Q26852458 | ||
| Cell entry of enveloped viruses | Q26863682 | ||
| The molecular basis of HIV entry | Q26863686 | ||
| Rabies molecular virology, diagnosis, prevention and treatment | Q26864666 | ||
| West Nile Virus: biology, transmission, and human infection | Q26865618 | ||
| The molecular basis of herpes simplex virus latency | Q27001272 | ||
| Poxvirus cell entry: how many proteins does it take? | Q27002455 | ||
| The choreography of HIV-1 proteolytic processing and virion assembly | Q27009643 | ||
| Principles of virus structural organization | Q27021684 | ||
| A structural and functional perspective of alphavirus replication and assembly | Q27490173 | ||
| Dealing with low pH: entry and exit of alphaviruses and flaviviruses | Q27490433 | ||
| The ins and outs of four-tunneled Reoviridae RNA-dependent RNA polymerases | Q27490574 | ||
| Mumps | Q28272753 | ||
| Review, part 1: Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy | Q28288444 | ||
| Combating enterovirus replication: State-of-the-art on antiviral research | Q29038131 | ||
| Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control. | Q30227769 | ||
| Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
| Influenza viruses: from birds to humans | Q30411865 | ||
| Assembly and architecture of HIV. | Q30455050 | ||
| Coronaviruses post-SARS: update on replication and pathogenesis | Q33694361 | ||
| Recent advances in the molecular and cellular biology of bunyaviruses | Q34002210 | ||
| Paramyxovirus assembly and budding: building particles that transmit infections | Q34020498 | ||
| A cutting-edge view on the current state of antiviral drug development | Q34036018 | ||
| Coronavirus pathogenesis | Q34233548 | ||
| Bunyavirus: structure and replication | Q34251194 | ||
| Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis | Q34280356 | ||
| Herpes virus fusion and entry: a story with many characters. | Q34285628 | ||
| Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. | Q34550271 | ||
| Retroviral integrase proteins and HIV-1 DNA integration | Q34643561 | ||
| Enterovirus infections of the central nervous system | Q34697319 | ||
| Smallpox vaccines: targets of protective immunity | Q34780607 | ||
| Influenza virus assembly and budding | Q34913111 | ||
| Review: The neurobiology of varicella zoster virus infection | Q35223289 | ||
| Non-template functions of viral RNA in picornavirus replication | Q35581640 | ||
| Arboviral encephalitides: transmission, emergence, and pathogenesis | Q35778817 | ||
| Measles virus, immune control, and persistence | Q35870777 | ||
| Measles, mumps, and rubella | Q35908453 | ||
| Paramyxovirus fusion and entry: multiple paths to a common end | Q35943669 | ||
| Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise | Q36435971 | ||
| From touchdown to transcription: the reovirus cell entry pathway | Q36467525 | ||
| Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. | Q36486818 | ||
| Review part 2: Human herpesvirus‐6 in central nervous system diseases | Q36592322 | ||
| Structural insights into the coupling of virion assembly and rotavirus replication | Q37167334 | ||
| Powassan encephalitis and Colorado tick fever | Q37255531 | ||
| Congenital rubella syndrome--major review | Q37359045 | ||
| Innate immunity to virus infection. | Q37361448 | ||
| The measles virus replication cycle. | Q37386893 | ||
| The regulation of disassembly of alphavirus cores | Q37395848 | ||
| Chikungunya and the nervous system: what we do and do not know | Q37410954 | ||
| Viral and host proteins involved in picornavirus life cycle | Q37448468 | ||
| Herpesvirus assembly: an update | Q37570980 | ||
| Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus | Q37660700 | ||
| Rubella virus capsid protein: a small protein with big functions | Q37721412 | ||
| Molecular mechanisms involved in the early steps of flavivirus cell entry | Q37792350 | ||
| New insights into structure and replication of the hepatitis C virus and clinical implications | Q37801595 | ||
| Cell entry of enveloped viruses. | Q37839350 | ||
| Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals | Q37847681 | ||
| Herpesviruses remodel host membranes for virus egress | Q37865385 | ||
| West Nile virus: the complex biology of an emerging pathogen | Q37876095 | ||
| Rabies virus transcription and replication | Q37877948 | ||
| Rabies virus assembly and budding. | Q37877949 | ||
| Therapy of human rabies. | Q37877967 | ||
| The human Parechoviruses: an overview | Q37898785 | ||
| Mechanistic intersections between picornavirus translation and RNA replication | Q37901621 | ||
| Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses | Q37909045 | ||
| Neuroinvasive flavivirus infections | Q37956596 | ||
| Status of human monkeypox: clinical disease, epidemiology and research | Q37970180 | ||
| HIV-associated neurological disorders: a guide to pharmacotherapy | Q37971469 | ||
| Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies | Q37980042 | ||
| Molecular mechanisms of HIV entry | Q37980628 | ||
| Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. | Q37980944 | ||
| Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure | Q37985217 | ||
| Poxvirus host cell entry. | Q37996243 | ||
| The role of receptor binding specificity in interspecies transmission of influenza viruses | Q37996781 | ||
| Current therapies and future perspectives in subacute sclerosing panencephalitis | Q37997097 | ||
| The pathogenesis of measles | Q38000781 | ||
| The role of vaccination in rabies prevention | Q38002621 | ||
| Varicella-zoster virus: Prevention through vaccination | Q38003269 | ||
| Features of varicella zoster virus myelitis and dependence on immune status | Q38008113 | ||
| Epstein-Barr virus cause of multiple sclerosis | Q38012319 | ||
| Flaviviruses and flavivirus vaccines | Q38017388 | ||
| Pathogenesis of influenza virus infections: the good, the bad and the ugly | Q38019628 | ||
| Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? | Q38022320 | ||
| Genetics and reverse genetics of rotavirus | Q38023008 | ||
| Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis | Q38028997 | ||
| Measles virus and associated central nervous system sequelae | Q38034298 | ||
| Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms | Q38040444 | ||
| Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation | Q38047084 | ||
| HTLV-1: persistence and pathogenesis | Q38065393 | ||
| P921 | main subject | virology | Q7215 |
| P1104 | number of pages | 22 | |
| P304 | page(s) | 45-66 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn | Q26842295 |
| P1476 | title | Basics of virology | |
| P478 | volume | 123 |
Search more.